In Coding
Mar 3rd, 2014
The Centers for Medicare & Medicaid Services (CMS) has removed the coverage of evidence (CED) requirement in the national coverage determination (NCD) for fluorodeoxyglucose (FDG) positron emission tomography (PET) for solid tumors, effective June 11, 2013. CMS will cover three FDG PET scans (without the CED requirement) when used to guide subsequent management of anti-tumor ...
In Billing
Oct 1st, 2010
Comments Off on CMS Amends NCD for FDG PET
The Centers for Medicare & Medicaid Services (CMS) announced Sept. 24 that it is amending the National Coverage Determination (NCD) for Positron Emission Tomography (PET) for Oncologic Conditions. The government agency issued a decision memo effective Aug. 4 that retracts its restriction of one initial PET scan for therapeutic purposes related to the initial treatment strategy ...
In Coding
Oct 21st, 2009
Long-discussed reconsideration of F-18 fluoro-D-glucose (FDG) positron emission tomography (PET) scanning of solid tumors and myelomas has been completed by the Centers for the Medicare & Medicaid Services (CMS). The changes, to be implemented Oct. 30 and retroactively effective to April 3, are extensive. FDG PET Rules Finalized, Effective April ’09 was last modified: July 5th, ...
In CMS
Oct 5th, 2009
Recent changes to Pub. 100-03 of the Medicare National Coverage Determinations (NCD) Manual may soon affect the way your practice bills for f-18 flouro-D-glucose positron emission tomography (FDG PET) imaging services. New FDG Reporting Requirements Delayed was last modified: July 5th, 2011 by admin aapc...
In CMS
Aug 3rd, 2009
The Centers for Medicare & Medicaid Services (CMS) is revising Section 220.6 of the National Coverage Determinaton (NCD) Manual to reflect a new coverage framework for the use of F-18 flouro-D-glucose positron emission tomography (FDG PET) in determining initial and subsequent onocologic treatment strategies, as outlined in the NCD (CAG-00181R). New FDG PET Reporting Requirements was last modif...